Skip to content
New issue

Have a question about this project? Sign up for a free GitHub account to open an issue and contact its maintainers and the community.

By clicking “Sign up for GitHub”, you agree to our terms of service and privacy statement. We’ll occasionally send you account related emails.

Already on GitHub? Sign in to your account

Obsoletion request: hypoxanthine salvage GO:0043103 #28231

Open
ValWood opened this issue Jun 20, 2024 · 14 comments
Open

Obsoletion request: hypoxanthine salvage GO:0043103 #28231

ValWood opened this issue Jun 20, 2024 · 14 comments

Comments

@ValWood
Copy link
Contributor

ValWood commented Jun 20, 2024

Please provide as much information as you can:

  • GO term ID and Label

GO:0043103 hypoxanthine salvage

  • Reason for deprecation Put an x in the appropriate box:
  • The reason for obsoletion is that this term was an unnecessary grouping term.

I'm not sure that we need this term. hypoxanthine appears to be an intermediate in IMP salvage. We noticed when modelling nucleotide metabolism, that this BP term was only used for 2 steps in the the IMP salvage pathway.

See
http://noctua.geneontology.org/workbench/noctua-visual-pathway-editor/?barista_token=b9lbuk0h1mdk0h925a9l&model_id=gomodel:663d668500001911

GO-hypoxanthine

@pgaudet @deustp01 do you agree?

  • "Replace by" term (ID and label)
    If all annotations can safely be moved to that term

IMP salvage

  • Are there annotations to this term?
  • How many EXP: 6

PomBase 2
SGD 2
UniProt 1
E coli wiki 1

  • Are there mappings and cross references to this term? (InterPro, Keywords; check QuickGO cross-references section)

  • Is this term in a subset? (check the AmiGO page for that term)

  • Any other information


CC @PCarme

@deustp01
Copy link

deustp01 commented Jun 20, 2024

do you agree?

We don't subdivide the process of purine catabolism, seeing it as an interconnected single process, so the obsoletion looks fine to me, but also ask David @ukemi - he's the local expert.

@ValWood
Copy link
Contributor Author

ValWood commented Jun 20, 2024

It seems to be used for Aah1/Dea2, Hpt1/HPRT1 which have hypoxanthine as input/output

@ukemi
Copy link
Contributor

ukemi commented Jun 20, 2024

I suspect it is there because of clinical significance. eg. PMID:3818951

@ValWood ValWood self-assigned this Jun 24, 2024
@ValWood
Copy link
Contributor Author

ValWood commented Jun 24, 2024

Is that a reason to include it as a term? The activities will be there and the overall process.

We could add "hypoxanthine salvage" as a related synonym for "IMP salvage" and any other end points?

@pgaudet

@ValWood
Copy link
Contributor Author

ValWood commented Jul 12, 2024

@pgaudet do you agree with this change?

@pgaudet
Copy link
Contributor

pgaudet commented Jul 12, 2024

I dont know, you write that it's an unnecessary grouping term, but I dont see any children.

@ValWood
Copy link
Contributor Author

ValWood commented Jul 12, 2024

I mean it's an unecessary intermediate, I don't know what we call that. It's an intermediate in IMP salvage (and possibly othernucleotide salvage pathways)

@pgaudet
Copy link
Contributor

pgaudet commented Jul 12, 2024

Is it? Here it seems to be an 'input' :
2023 review:
https://www.sciencedirect.com/science/article/pii/S0028390822004294

@pgaudet
Copy link
Contributor

pgaudet commented Jul 12, 2024

Granted, it's quite underannotated. What we need to think about how to clearly define this pathway with a start and end. In this case hypoxanthine may be the start of some purine salvage pathway.

@ValWood
Copy link
Contributor Author

ValWood commented Jul 12, 2024

The pathway begins with adenine
It is an input.

So, we have
dea2 an adenine deaminase annotated to IMP salvage and hypoxanthine salvage

Then the next step
hpt1 hypoxanthine phosphoribosyltransferase activity
creates IMP from hypoxanthine

the hypoxanthine salvage seems unnecessary if it isn't an endpoint.

@ValWood
Copy link
Contributor Author

ValWood commented Jul 12, 2024

There may be other starting points but hypoxanthine isn't the end point?

@ValWood ValWood closed this as completed Jul 12, 2024
@ValWood ValWood reopened this Jul 12, 2024
@deustp01
Copy link

this case hypoxanthine may be the start of some purine salvage pathway.

For what it's worth, here is our view of the purine salvage and catabolism processes in humans. We treat hypoxanthine as one of the start points for catabolism and it is one of the molecules generated by salvage so it could be an end point there.

@ValWood
Copy link
Contributor Author

ValWood commented Jul 12, 2024

I'm happy to close this one.

A couple of weeks ago, instead of opening tickets, I began a list of process terms that seemed superfluous to the GO-CAM models (i.e. because they seemed like an intermediate step rather than a start point or end point)
When I began opening tickets I didn't think there would be so many.

It will probably be better to review these at the end in case we missed something or if there are organism-specific differences.

I will continue to open tickets if there is a clear-cut case, but this one seems more cpmplicated

@deustp01 I tried to look at
https://reactome.org/PathwayBrowser/#/R-HSA-74217 but I could not get it to load. Is that just me?

@deustp01
Copy link

I could not get it to load.

It worked for me when I was composing the message, and also just now. We have been having intermittent loading problems, though, so try again and if the problem persists send a message to help@reactome.org. Thanks

Sign up for free to join this conversation on GitHub. Already have an account? Sign in to comment
Projects
None yet
Development

No branches or pull requests

4 participants